Gan & Lee pharmaceutical Ltd. is one of the leading pharmaceutical companies in China focusing on biosynthetic human insulin. Since its establishment in 1994, we have kept the leader status in China in the research, development and production of biosynthetic insulin and insulin analogs.
Our plant, located in Beijing, is one of the most modern insulin plants in Asia, even in the whole world. Annual output capacity is over 1000kg insulin API with filling capacity over 100 million cartridges.
Prandilin®25 is effective in controlling both postprandial and fasting glucose, more rapid and of short duration compared with regular human insulin.
